Aquestive Therapeutics Inc. (AQST)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2024, 4:20 pm based on SEC 13F filings Last update: November 14, 2024, 4:20 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	BioImpact Capital Mpm Capital	1,796,750	$8,947,815		1.34%
2.	Citadel Investment Group Ken Griffin	871,833	$4,341,728	+420%	0%
3.	Woodline Partners Michael Rockefeller And Karl Kroeker	816,252	$4,064,935	+36%	0.03%
4.	DAFNA Capital Management Nathan Fischel	589,561	$2,936,014	+12%	0.69%
5.	Bracebridge Capital Nancy Zimmerman And Gabriel Sunshine	428,571	$2,134,284		0.34%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Boyd	$0.81	5,000	Officer	59,532	2022-06-14	Filing
Barber	$0.96	91,743	Officer	193,702	2022-06-08	Filing
Schobel	$0.96	45,871	Officer	882,871	2022-06-08	Filing
Boyd	$0.96	2,293	Officer	54,532	2022-06-08	Filing
Braender	$0.96	13,761	Officer	38,761	2022-06-08	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Remaining Holdings	Date	Form 4
Schobel	$6.00	50,000	984,476	2024-03-15	Filing
Schobel	$5.19	25,000	1,040,371	2024-03-08	Filing
Schobel	$6.75	23,460	837,000	2021-02-10	Filing
Schobel	$6.75	11,540	860,460	2021-02-09	Filing
Schobel	$6.50	40,792	872,000	2021-02-08	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Bratton Capital Management, L.p.	9,810,958	$19,818,135	100%
2.	Vanguard Group Inc	1,889,053	$3,815,887	0%
3.	Essex Investment Management Co Llc	846,167	$1,709,257	0.33%
4.	Vahanian & Associates Financial Planning Inc.	591,608	$1,195,048	4.72%
5.	Geode Capital Management, Llc	494,902	$999,926	0%